Carl Voegtlin
Carl Voegtlin | |
|---|---|
| Born | July 28, 1879 |
| Died | April 9, 1960 (aged 80) Washington, D.C., US |
| Occupation(s) | pharmacologist, organic chemist |
| Academic background | |
| Education | University of Basel University of Munich University of Freiburg |
| Doctoral advisor | Ludwig Gattermann |
| Academic work | |
| Institutions | University of Wisconsin–Madison Johns Hopkins University United States Public Health Service National Cancer Institute |
Carl Voegtlin (July 28, 1879 – April 9, 1960), also Karl Voegtlin, was a Swiss-American pharmacologist, organic chemist, and the first director of the U.S. National Cancer Institute. He is known for his research into the biochemical effects of cancer, contributions to the pharmacology of arsenicals and the discovery, with Homer Smith, of mapharsen as the active agent in Paul Ehrlich's Salvarsan.